95 related articles for article (PubMed ID: 2706131)
1. Non-palpable invasive breast carcinomas from the Stockholm screening project.
von Rosen A; Frisell J; Glas U; Hellström L; Nilsson R; Skoog L; Auer G
Acta Oncol; 1989; 28(1):23-7. PubMed ID: 2706131
[TBL] [Abstract][Full Text] [Related]
2. Cytophotometrical and biochemical characterization of nonpalpable, mammographically detected mammary adenocarcinomas.
Fallenius AG; Skoog LK; Svane GE; Auer GU
Cytometry; 1984 Jul; 5(4):426-9. PubMed ID: 6468181
[TBL] [Abstract][Full Text] [Related]
3. DNA ploidy in screening-detected non-palpable mammary carcinomas.
von Rosen A; Frisell J; Azavedo E; Auer G
Eur J Surg Oncol; 1990 Dec; 16(6):471-4. PubMed ID: 2174806
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.
von Rosen A; Rutqvist LE; Carstensen J; Fallenius A; Skoog L; Auer G
Breast Cancer Res Treat; 1989 Jan; 13(1):23-32. PubMed ID: 2706326
[TBL] [Abstract][Full Text] [Related]
5. Nuclear DNA content, histological grade, and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas.
Azavedo E; Fallenius A; Svane G; Auer G
Am J Clin Oncol; 1990 Feb; 13(1):23-7. PubMed ID: 2154920
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic and cytochemical characteristics of interval breast carcinomas from the Stockholm Mammography Screening Project.
von Rosen A; Frisell J; Nilsson R; Wiege M; Auer G
Acta Oncol; 1992; 31(4):399-402. PubMed ID: 1321649
[TBL] [Abstract][Full Text] [Related]
7. Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas.
Auer GU; Caspersson TO; Gustafsson SA; Humla SA; Ljung BM; Nordenskjöld BA; Silfverswärd C; Wallgren AS
Anal Quant Cytol; 1980 Dec; 2(4):280-4. PubMed ID: 7469203
[TBL] [Abstract][Full Text] [Related]
8. Relationship between certain radiographic and biologic characteristics in breast cancer.
von Rosen A; Wiege M; Törnberg B; Hellström L; Skoog L; Somell A; Auer G
Acta Oncol; 1987; 26(2):89-93. PubMed ID: 3606869
[TBL] [Abstract][Full Text] [Related]
9. [The treatment of non-palpable breast tumors found during mammographic screening at our hospital].
Henrietta B; Eva S; Eniko N
Magy Seb; 2005 Jun; 58(3):162-6. PubMed ID: 16167469
[TBL] [Abstract][Full Text] [Related]
10. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
11. Comparison of estrogen receptor, progesterone receptor and HER2 results in concurrent ipsilateral samples with invasive breast carcinoma: a retrospective study of 246 biopsies from 119 patients.
Singh K; Wang Y; Marketkar S; Kalife ET; Steinhoff MM
Hum Pathol; 2017 Jul; 65():123-132. PubMed ID: 28457730
[TBL] [Abstract][Full Text] [Related]
12. Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group.
Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
Int J Cancer; 1992 Apr; 51(1):28-33. PubMed ID: 1563841
[TBL] [Abstract][Full Text] [Related]
13. Assessment of malignancy potential in mammary carcinoma in elderly patients.
von Rosen A; Gardelin A; Auer G
Am J Clin Oncol; 1987 Feb; 10(1):61-4. PubMed ID: 3825995
[TBL] [Abstract][Full Text] [Related]
14. P53 expression in breast cancer.
Cattoretti G; Rilke F; Andreola S; D'Amato L; Delia D
Int J Cancer; 1988 Feb; 41(2):178-83. PubMed ID: 3276632
[TBL] [Abstract][Full Text] [Related]
15. Ploidy, proliferative activity and estrogen receptor content in human breast cancer.
Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G
Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric DNA analysis of invasive carcinomas detected by screening mammography: use of specimen mammography-guided fine-needle aspirates.
Stomper PC; DeBloom JR; Levine E; Budnick RM; Stewart CC
Clin Cancer Res; 1998 Jul; 4(7):1789-95. PubMed ID: 9676857
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry.
Helin HJ; Helle MJ; Kallioniemi OP; Isola JJ
Cancer; 1989 May; 63(9):1761-7. PubMed ID: 2649227
[TBL] [Abstract][Full Text] [Related]
18. Interrelations between cellular DNA content, S-phase fraction, hormone receptor status and age in primary breast cancer. A series of 1,342 consecutively detected tumors. South-East Sweden Breast Cancer Group.
Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
Acta Oncol; 1992; 31(3):283-92. PubMed ID: 1622647
[TBL] [Abstract][Full Text] [Related]
19. Relationship between mammographic pattern and estrogen receptor content in breast cancer.
Broberg A; Glas U; Gustafsson SA; Hellström L; Somell A
Breast Cancer Res Treat; 1983; 3(2):201-7. PubMed ID: 6616077
[TBL] [Abstract][Full Text] [Related]
20. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
